Martin Steinhoff

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi IL-33: a novel danger signal system in atopic dermatitis
    Ferda Cevikbas
    Department of Dermatology and Surgery, University of California, San Francisco, San Francisco, California 94143, USA
    J Invest Dermatol 132:1326-9. 2012
  2. ncbi Pruritus: management algorithms and experimental therapies
    Martin Steinhoff
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Semin Cutan Med Surg 30:127-37. 2011
  3. ncbi Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development
    Ferda Cevikbas
    Department of Dermatology, University of California, San Francisco, CA 94143 0660, USA
    CNS Neurosci Ther 17:742-9. 2011
  4. ncbi "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis
    Peter M Elias
    Dermatology Service, Veterans Affairs Medical Center, and Department of Dermatology, University of California, San Francisco, California 94121, USA
    J Invest Dermatol 128:1067-70. 2008
  5. ncbi Mouse model of touch-evoked itch (alloknesis)
    Tasuku Akiyama
    Department of Neurobiology, Physiology, and Behavior, University of California, Davis, Davis, California, USA
    J Invest Dermatol 132:1886-91. 2012
  6. ncbi Management of itch in atopic dermatitis
    Judith Hong
    Department of Dermatology, University of California San Francisco, San Francisco, CA 94143, USA
    Semin Cutan Med Surg 30:71-86. 2011
  7. ncbi Pruritus and renal failure
    Timothy G Berger
    Department of Dermatology, University of California San Francisco, San Francisco, CA 94143, USA
    Semin Cutan Med Surg 30:99-100. 2011
  8. ncbi Anatomy and neurophysiology of pruritus
    Akihiko Ikoma
    Department of Dermatology and Surgery, University of California, San Francisco, San Francisco, CA, USA
    Semin Cutan Med Surg 30:64-70. 2011
  9. ncbi Proteinase-activated receptors 1 and 2 regulate invasive behavior of human melanoma cells via activation of protein kinase D1
    Cordula Kempkes
    Department of Dermatology and IZKF Münster, University of Munster, Munster, Germany
    J Invest Dermatol 132:375-84. 2012
  10. ncbi Clinical, cellular, and molecular aspects in the pathophysiology of rosacea
    Martin Steinhoff
    Departments of Dermatology and Surgery, University of California, San Francisco, San Francisco, California, USA
    J Investig Dermatol Symp Proc 15:2-11. 2011

Collaborators

Detail Information

Publications13

  1. ncbi IL-33: a novel danger signal system in atopic dermatitis
    Ferda Cevikbas
    Department of Dermatology and Surgery, University of California, San Francisco, San Francisco, California 94143, USA
    J Invest Dermatol 132:1326-9. 2012
    ..On the other hand, several studies have reported on the inhibitory effects of sST2 in inflammatory and fibrotic diseases, suggesting that IL-33/ST2 is a unique cytokine with potential pro- and anti-inflammatory effects...
  2. ncbi Pruritus: management algorithms and experimental therapies
    Martin Steinhoff
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Semin Cutan Med Surg 30:127-37. 2011
    ..Finally, we summarize current exciting developments of experimental strategies in itch research and in clinical development for itch therapy...
  3. ncbi Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development
    Ferda Cevikbas
    Department of Dermatology, University of California, San Francisco, CA 94143 0660, USA
    CNS Neurosci Ther 17:742-9. 2011
    ..Thus, the identification of itch-specific receptors and understanding itch-related circuits in the spinal cord may be innovative strategies for the development of novel antipruritic drugs...
  4. ncbi "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis
    Peter M Elias
    Dermatology Service, Veterans Affairs Medical Center, and Department of Dermatology, University of California, San Francisco, California 94121, USA
    J Invest Dermatol 128:1067-70. 2008
    ..This cycle comprises an "outside-inside-outside" model of AD pathogenesis (Elias et al., in press)...
  5. ncbi Mouse model of touch-evoked itch (alloknesis)
    Tasuku Akiyama
    Department of Neurobiology, Physiology, and Behavior, University of California, Davis, Davis, California, USA
    J Invest Dermatol 132:1886-91. 2012
    ..In mice with experimental dry skin, there was a time-dependent increase in spontaneous and touch-evoked scratching. This animal model appears to be useful to investigate neural mechanisms of itch and alloknesis...
  6. ncbi Management of itch in atopic dermatitis
    Judith Hong
    Department of Dermatology, University of California San Francisco, San Francisco, CA 94143, USA
    Semin Cutan Med Surg 30:71-86. 2011
    ..This review highlights various topical, systemic, and complementary and alternative therapies, as well as provide a therapeutic ladder for optimized long-term control of itch in atopic dermatitis...
  7. ncbi Pruritus and renal failure
    Timothy G Berger
    Department of Dermatology, University of California San Francisco, San Francisco, CA 94143, USA
    Semin Cutan Med Surg 30:99-100. 2011
    ..Gabapentin has been recently discovered as an effective agent for the patient with ESRD pruritus. Kappa opiate agonists are promising new therapeutic options...
  8. ncbi Anatomy and neurophysiology of pruritus
    Akihiko Ikoma
    Department of Dermatology and Surgery, University of California, San Francisco, San Francisco, CA, USA
    Semin Cutan Med Surg 30:64-70. 2011
    ..Itch sensitization must also be considered in discussions of itch. This review highlights anatomical and functional properties of itch pathways and their relation to understanding itch perception and pruritic diseases...
  9. ncbi Proteinase-activated receptors 1 and 2 regulate invasive behavior of human melanoma cells via activation of protein kinase D1
    Cordula Kempkes
    Department of Dermatology and IZKF Münster, University of Munster, Munster, Germany
    J Invest Dermatol 132:375-84. 2012
    ..Inactivation of the PKD1 pathway may be beneficial for the inhibition of PAR-induced melanoma proliferation and for maintenance of the inflammatory tumor environment...
  10. ncbi Clinical, cellular, and molecular aspects in the pathophysiology of rosacea
    Martin Steinhoff
    Departments of Dermatology and Surgery, University of California, San Francisco, San Francisco, California, USA
    J Investig Dermatol Symp Proc 15:2-11. 2011
    ..This review highlights recent molecular (gene array) and cellular findings and aims to integrate the different body defense mechanisms into a modern concept of rosacea pathophysiology...
  11. ncbi Innovative management of pruritus
    Jamison D Feramisco
    Department of Dermatology, University of California at San Francisco, 1701 Divisadero Street, 3rd Floor, San Francisco, CA 94115, USA
    Dermatol Clin 28:467-78. 2010
    ..They also addresses mechanisms and management modalities of itch in common systemic diseases, including cholestasis, uremia, and neuropathic dysfunction...
  12. ncbi Pruritus in elderly patients--eruptions of senescence
    Timothy G Berger
    Department of Dermatology, University of California San Francisco, San Francisco, CA 94143, USA
    Semin Cutan Med Surg 30:113-7. 2011
    ....
  13. ncbi Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates
    Andrea L Suarez
    Department of Dermatology, University of Colorado Denver, School of Medicine, Aurora, USA
    Acta Derm Venereol 92:7-15. 2012
    ....